Erythromycin G(616234-56-1)
- Name: Erythromycin G
- Synonyms:4-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12-dihydroxy-3-hydroxymethyl-5,7,9,11,13-pentametehyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione;erythromycin G
- Molecular Formula:C37H67NO13
- Molecular Weight:733.9
- CAS Registry Number:616234-56-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.616234-56-1 Erythromycin Impurity 4
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.616234-56-1 Erythromycin EP Impurity M
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 158758-41-9/Shermilamine C
- 64825-80-5/12-Epi-Deoxoscalarin
- 306292-65-9/N-Ethyl-N'-[[2-[[4-(ethylamino)butylamino]methyl]cyclopropyl]methyl]butane-1,4-diamine;tetrahydrochloride
- 194280-90-5/S-Methyl-dihydro-zip-SO
- 156740-75-9/Axitirome, (R)-
- 3520-48-7/Aminophenazone 8-hydroxyquinolin-7-sulfonate
- 162854-21-9/3-[3,5-Dimethyl-4-[3-[3-[(methylsulfonyl)methyl]-5-isoxazolyl]propoxy]phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole
- 677000-30-5/(18F)Fe-spa-rq
- 639089-72-8/Tozasertib N-oxide, (piperazine-N-oxide)-
- 149092-57-9/3-[(Iodomethyl)thio]-1-(triphenylmethyl)-1H-1,2,4-triazole
- 200433-03-0/FR-181157 free acid
- 340984-83-0/Benzamide, 4-amino-5-chloro-N-(1-((3-fluoro-4-methoxyphenyl)methyl)-4-piperidinyl)-2-(2-hydroxyethoxy)-, monohydrochloride
- 218936-89-1/(4S,5R)-Antillatoxin
- 187086-12-0/Propanamide, 2,2,3,3,3-pentafluoro-N-(5,6,7,9-tetrahydro-1,2,3-trimethoxy-10-(methylthio)-9-oxobenzo(a)heptalen-7-yl)-, (S)-
- 157665-30-0/N-[2-Fluoro-4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]benzoyl]-L-glutamic acid
- 194798-94-2/(E)-(+)-2-(2,4-Difluorophenyl)-1-{3-[4-(2,2,3,3-tetrafluoropropoxy)styryl]-1H-1,2,4-triazol-1-YL}-3-(1H-1,2,4-triazol-1-YL)propan-2-OL
- 187086-15-3/Butanamide, 2,2,3,3,4,4,4-heptafluoro-N-(5,6,7,9-tetrahydro-1,2,3-trimethoxy-10-(methylthio)-9-oxobenzo(a)heptalen-7-yl)-, (S)-
- 117553-30-7/l-Aspartic acid dihexadecyl ester
- 273202-85-0/Lyngbyabellin A
- 616234-56-1/Erythromycin G
- 359844-70-5/Phomoxanthone B
- 11054-95-8/Davercin
- 161316-36-5/CID 10033210
- 914076-30-5/Erythromycin ethyl carbonate
- 155510-76-2/Ergosta-5,24-dien-26-oic acid, 1,3,11,22-tetrahydroxy-, 6-O-acetyl-2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester, (1alpha,3beta,11beta,22R,24E)-
- 793681-98-8/1,1'-(4-Methoxy-1,3-phenylene)bis[1,2-hydrazinedicarboxylic acid bis(2,2,2-trichloroethyl)] ester
- 219818-60-7/Manganese(III)meso-tetrakis(N-ethylpyridinium-2-yl) porphyrin chloride
- 81419-68-3/Amphotericin B 3-dimethylaminopropylamide
- 147228-63-5/Pentaspiro[3.1.1.1.1.3.1.1.1.1]nonadecane-2,2,14,14-tetracarboxamide, N,N',N'',N'''-tetrakis[2-(acetyloxy)-1,1-bis[(acetyloxy)methyl]ethyl]-
- 79144-32-4/1,2,3,6-Tetrahydro-1-methyl-4-pyridinol